Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Correcting Bioenvision Release Issued February 4, BW2423.


Business Editors

CORRECTION...by Bioenvision

--(BUSINESS WIRE)

In BW2423-2/4, (NY-BIOENVISION) Bioenvision Completes Acquisition of Pathagon, Inc released February 4, read the second graf xxx With the acquisition, Bioenvision adds the rights to two marketed anti-infective an·ti-in·fec·tive
adj.
Capable of preventing or counteracting infection.

n.
An anti-infective agent or drug.



anti-infective

1. counteracting infection.

2. a substance that counteracts infection.
 technologies, OLIGON(TM) and methylene blue methylene blue
n.
A basic aniline dye that forms a deep blue solution when dissolved in water and is used as a bacteriological stain and as an antidote for cyanide poisoning.
, to its portfolio (sted xxx With the acquisition, Bioenvision adds to its portfolio the rights to two FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved and marketed anti-infective technologies, OLIGON(TM) and methylene blue.)

Also, contact information xxx H.L. Lanzet, Inc., New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 Herbert Lanzet/DeeDee Lanzet, 212/687-0061 should be removed.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 5, 2002
Words:89
Previous Article:ADVISORY/Photo of the Victory Medals for the 2002 Olympic Winter Games is Available on BW PhotoWire/AP PhotoExpress, NewsCom and Business Wire's Web...
Next Article:Bioenvision Completes Acquisition of Pathagon, Inc; Pathagon Adds Two Proprietary, Marketed Technologies to Bioenvision Portfolio.



Related Articles
Bioenvision Reports Third Quarter Fiscal 2005 Financial Results.
Bioenvision to Restate Prior Period Financial Statements to Reflect Increase in Income Tax Benefit and Corresponding Decrease in Net Loss Available...
Bioenvision Reports Third Quarter Fiscal 2005 Financial Results.
Clofarabine European Marketing Authorization Application Status; Oral Explanation Scheduled for week of February 20th 2006.
Bioenvision to Host Second Quarter 2006 Financial Results Conference Call.
Bioenvision Reports Second Quarter 2006 Financial Results.
Bioenvision to Host Conference Call Following Positive Opinion of Clofarabine from the European Medicines Agency.
Bioenvision Names New Member to Board of Directors.
Bioenvision to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on Thursday, February 8, 2007.
Bioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO Capital.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles